Impact of aspirin on trophoblastic invasion in women with abnormal uterine artery Doppler at 11–14 weeks: a randomized controlled study

Ultrasound in Obstetrics and Gynecology

Volumn 49, Issue 4, 2017, Pages 435-441

  Scazzocchio, E ^a   Oros, D ^b   Diaz, D ^c   Ramirez, J C ^c   Ricart, M ^a   Meler, E ^a   Gonzalez de Aguero R ^b   Gratacos, E ^c   Figueras, F ^c  

^a INSTITUT UNIVERSITARI DEXEUS   (Spain)

^b INSTITUTO DE INVESTIGACIÓN SANITARIA ARAGÓN IIS ARAGÓN   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

aspirin; first trimester screening; pre eclampsia; prevention; uterine artery Doppler

Indexed keywords

ACETYLSALICYLIC ACID;

ABNORMALITIES; ADULT; CELL MOTION; CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DOPPLER ULTRASONOGRAPHY; DRUG EFFECTS; FEMALE; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; HUMAN; MULTICENTER STUDY; PHASE 2 CLINICAL TRIAL; PRE-ECLAMPSIA; PREGNANCY; RANDOMIZED CONTROLLED TRIAL; SECOND TRIMESTER PREGNANCY; SMALL FOR DATE INFANT; TREATMENT OUTCOME; TROPHOBLAST; UTERINE ARTERY;

ADULT; ASPIRIN; CELL MOVEMENT; FEMALE; HUMANS; INFANT, SMALL FOR GESTATIONAL AGE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; TREATMENT OUTCOME; TROPHOBLASTS; ULTRASONOGRAPHY, DOPPLER; ULTRASONOGRAPHY, PRENATAL; UTERINE ARTERY;

EID: 85017242233     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.17351     Document Type: Article

References (35)

1. Lisonkova S, Sabr Y, Mayer C, Young C, Skoll A, Joseph KS. Maternal morbidity associated with early-onset and late-onset preeclampsia. Obstet Gynecol 2014; 124: 771–781.
2. Abalos E, Cuesta C, Carroli G, Qureshi Z, Widmer M, Vogel JP, Souza JP; WHO Multicountry Survey on Maternal and Newborn Health Research Network. Pre-eclampsia, eclampsia and adverse maternal and perinatal outcomes: a secondary analysis of the World Health Organization Multicountry Survey on Maternal and Newborn Health. BJOG 2014; 121 Suppl 1: 14–24.
3. Creanga AA, Berg CJ, Syverson C, Seed K, Bruce FC, Callaghan WM. Pregnancy-related mortality in the United States, 2006-2010. Obstet Gynecol 2015; 125: 5–12.
4. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science 2005; 308: 1592–1594.
5. Lin S, Shimizu I, Suehara N, Nakayama M, Aono T. Uterine artery Doppler velocimetry in relation to trophoblast migration into the myometrium of the placental bed. Obstet Gynecol 1995; 85: 760–765.
6. 133Xe method. Acta Obstet Gynecol Scand 1980; 59: 7–10.
7. Papageorghiou AT, Yu CK, Bindra R, Pandis G, Nicolaides KH. Multicenter screening for pre-eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation. Ultrasound Obstet Gynecol 2001; 18: 441–449.
8. Roberge S, Giguere Y, Villa P, Nicolaides K, Vainio M, Forest JC, von Dadelszen P, Vaiman D, Tapp S, Bujold E. Early administration of low-dose aspirin for the prevention of severe and mild preeclampsia: a systematic review and meta-analysis. Am J Perinatol 2012; 29: 551–556.
9. Askie LM, Duley L, Henderson-Smart DJ, Stewart LA. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet 2007; 369: 1791–1798.
10. Bujold E, Morency AM, Roberge S, Lacasse Y, Forest JC, Giguere Y. Acetylsalicylic acid for the prevention of preeclampsia and intra-uterine growth restriction in women with abnormal uterine artery Doppler: a systematic review and meta-analysis. J Obstet Gynaecol Can 2009; 31: 818–826.
11. Prefumo F, Sebire NJ, Thilaganathan B. Decreased endovascular trophoblast invasion in first trimester pregnancies with high-resistance uterine artery Doppler indices. Hum Reprod 2004; 19: 206–209.
12. Haapsamo M, Martikainen H, Rasanen J. Low-dose aspirin reduces uteroplacental vascular impedance in early and mid gestation in IVF and ICSI patients: a randomized, placebo-controlled double-blind study. Ultrasound Obstet Gynecol 2008; 32: 687–693.
13. Llurba E, Turan O, Kasdaglis T, Harman CR, Baschat AA. Emergence of late-onset placental dysfunction: relationship to the change in uterine artery blood flow resistance between the first and third trimesters. Am J Perinatol 2013; 30: 505–512.
14. Gomez O, Figueras F, Fernandez S, Bennasar M, Martinez JM, Puerto B, Gratacós E. Reference ranges for uterine artery mean pulsatility index at 11–41 weeks of gestation. Ultrasound Obstet Gynecol 2008; 32: 128–132.
15. Robinson HP, Sweet EM, Adam AH. The accuracy of radiological estimates of gestational age using early fetal crown-rump length measurements by ultrasound as a basis for comparison. Br J Obstet Gynaecol 1979; 86: 525–528.
16. Figueras F, Torrents M, Munoz A, Comas C, Antolin E, Echevarria M, Mallafré J, Carrera JM. References intervals for fetal biometrical parameters. Eur J Obstet Gynecol Reprod Biol 2002; 105: 25–30.
17. Hadlock FP, Harrist RB, Martinez-Poyer J. In utero analysis of fetal growth: a sonographic weight standard. Radiology 1991; 181: 129–133.
18. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001; 20: IX–XIV.
19. Figueras F, Meler E, Iraola A, Eixarch E, Coll O, Figueras J, Francis A, Gratacos E, Gardosi J. Customized birthweight standards for a Spanish population. Eur J Obstet Gynecol Reprod Biol 2008; 136: 20–24.
20. National Institute for Health and Clinical Excellence (NICE). Intrapartum care: care of healthy women and their babies during childbirth. NICE Clinical Guideline 55. NICE: London, 2012.
21. Gregg AR, Weiner CP. “Normal” umbilical arterial and venous acid-base and blood gas values. Clin Obstet Gynecol 1993; 36: 24–32.
22. Gomez O, Figueras F, Martinez JM, del Rio M, Palacio M, Eixarch E, Puerto B, Coll O, Cararach V, Vanrell JA. Sequential changes in uterine artery blood flow pattern between the first and second trimesters of gestation in relation to pregnancy outcome. Ultrasound Obstet Gynecol 2006; 28: 802–808.
23. Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, Forest JC, Giguère Y. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol 2010; 116: 402–414.
24. Steer CV, Tan SL, Dillon D, Mason BA, Campbell S. Vaginal color Doppler assessment of uterine artery impedance correlates with immunohistochemical markers of endometrial receptivity required for the implantation of an embryo. Fertil Steril 1995; 63: 101–108.
25. Rubinstein M, Marazzi A, Polak de Fried E. Low-dose aspirin treatment improves ovarian responsiveness, uterine and ovarian blood flow velocity, implantation, and pregnancy rates in patients undergoing in vitro fertilization: a prospective, randomized, double-blind placebo-controlled assay. Fertil Steril 1999; 71: 825–829.
26. Baschat AA, Poon L, Blitzer MG, Nicolaides K, Harman CR. Impact of 1st trimester aspirin on population prevalence of pre-eclampsia (OC 08.05). Ultrasound Obstet Gynecol 2009; 34(S1): 14.
27. Amin AR, Attur MG, Pillinger M, Abramson SB. The pleiotropic functions of aspirin: mechanisms of action. Cell Mol Life Sci 1999; 56: 305–312.
28. Roberge S, Sibai B, McCaw-Binns A, Bujold E. Low-dose aspirin in early gestation for prevention of preeclampsia and small-for-gestational-age neonates: Meta-analysis of large randomized trials. Am J Perinatol 2016; 6: e009897.
29. Villa PM, Kajantie E, Raikkonen K, Pesonen AK, Hamalainen E, Vainio M, Taipale P, Laivuori H; PREDO Study group. Aspirin in the prevention of pre-eclampsia in high-risk women: a randomised placebo-controlled PREDO Trial and a meta-analysis of randomised trials. BJOG 2013; 120: 64–74.
30. Cnossen JS, Morris RK, ter Riet G, Mol BW, van der Post JA, Coomarasamy A, Zwinderman AH, Robson SC, Bindels PJ, Kleijnen J, Khan KS. Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis. CMAJ 2008; 178: 701–711.
31. Plasencia W, Maiz N, Poon L, Yu C, Nicolaides KH. Uterine artery Doppler at 11 + 0 to 13 + 6 weeks and 21 + 0 to 24 + 6 weeks in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol 2008; 32: 138–146.
32. Odibo AO, Goetzinger KR, Odibo L, Tuuli MG. Early prediction and aspirin for prevention of pre-eclampsia (EPAPP) study: a randomized controlled trial. Ultrasound Obstet Gynecol 2015; 46: 414–418.
33. National Institute for Health and Clinical Excellence (NICE). Hypertension in pregnancy: the management of hypertensive disorders in pregnancy. NICE Clinical Guideline No. 107. Issued 2010, updated January 2011. http://www.nice.org.uk/guidance/cg107/evidence/full-guideline-134794333 [Accessed 20 January 2016].
34. World Health Organization (WHO). WHO Recommendations for Prevention and Treatment of Preeclampsia and Eclampsia. http://whqlibdoc.who.int/publications/2011/9789241548335_eng.pdf [Accessed 20 January 2016].
35. Henderson JT, Whitlock EP, O'Connor E, Senger CA, Thompson JH, Rowland MG. Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med 2014; 160: 695–703.